FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2777674964> ?p ?o ?g. }

• W2777674964 endingPage "503" @default.
• W2777674964 startingPage "494" @default.
• W2777674964 abstract "The triple-angiokinase inhibitor nintedanib is an orally available, potent, and selective inhibitor of tumor angiogenesis by blocking the tyrosine kinase activities of vascular endothelial growth factor receptor (VEGFR) 1-3, platelet-derived growth factor receptor (PDGFR)-α and -β, and fibroblast growth factor receptor (FGFR) 1-3. Nintedanib has received regulatory approval as second-line treatment of adenocarcinoma non-small cell lung cancer (NSCLC), in combination with docetaxel. In addition, nintedanib has been approved for the treatment of idiopathic lung fibrosis. Here we report the results from a broad kinase screen that identified additional kinases as targets for nintedanib in the low nanomolar range. Several of these kinases are known to be mutated or overexpressed and are involved in tumor development (discoidin domain receptor family, member 1 and 2, tropomyosin receptor kinase A (TRKA) and C, rearranged during transfection proto-oncogene [RET proto oncogene]), as well as in fibrotic diseases (e.g., DDRs). In tumor cell lines displaying molecular alterations in potential nintedanib targets, the inhibitor demonstrates direct antiproliferative effects: in the NSCLC cell line NCI-H1703 carrying a PDGFRα amplification (ampl.); the gastric cancer cell line KatoIII and the breast cancer cell line MFM223, both driven by a FGFR2 amplification; AN3CA (endometrial carcinoma) bearing a mutated FGFR2; the acute myeloid leukemia cell lines MOLM-13 and MV-4-11-B with FLT3 mutations; and the NSCLC adenocarcinoma LC-2/ad harboring a CCDC6-RET fusion. Potent kinase inhibition does not, however, strictly translate into antiproliferative activity, as demonstrated in the TRKA-dependent cell lines CUTO-3 and KM-12. Importantly, nintedanib treatment of NCI-H1703 tumor xenografts triggered effective tumor shrinkage, indicating a direct effect on the tumor cells in addition to the antiangiogenic effect on the tumor stroma. These findings will be instructive in guiding future genome-based clinical trials of nintedanib." @default.
• W2777674964 created "2018-01-05" @default.
• W2777674964 creator A5001388573 @default.
• W2777674964 creator A5003811693 @default.
• W2777674964 creator A5011186689 @default.
• W2777674964 creator A5034705456 @default.
• W2777674964 creator A5056562930 @default.
• W2777674964 creator A5057713208 @default.
• W2777674964 creator A5064561704 @default.
• W2777674964 creator A5065339919 @default.
• W2777674964 creator A5074720413 @default.
• W2777674964 creator A5075361012 @default.
• W2777674964 creator A5076653808 @default.
• W2777674964 date "2017-12-20" @default.
• W2777674964 modified "2023-09-27" @default.
• W2777674964 title "Triple Angiokinase Inhibitor Nintedanib Directly Inhibits Tumor Cell Growth and Induces Tumor Shrinkage via Blocking Oncogenic Receptor Tyrosine Kinases" @default.
• W2777674964 cites W164528865 @default.
• W2777674964 cites W1868766650 @default.
• W2777674964 cites W1968123283 @default.
• W2777674964 cites W1969897104 @default.
• W2777674964 cites W1973283880 @default.
• W2777674964 cites W1976498645 @default.
• W2777674964 cites W1979306439 @default.
• W2777674964 cites W1981278563 @default.
• W2777674964 cites W1986143876 @default.
• W2777674964 cites W2008550171 @default.
• W2777674964 cites W2016548318 @default.
• W2777674964 cites W2022307068 @default.
• W2777674964 cites W2022540958 @default.
• W2777674964 cites W2028238072 @default.
• W2777674964 cites W2043533051 @default.
• W2777674964 cites W2045695594 @default.
• W2777674964 cites W2059860479 @default.
• W2777674964 cites W2066680949 @default.
• W2777674964 cites W2068523052 @default.
• W2777674964 cites W2070841378 @default.
• W2777674964 cites W2089756110 @default.
• W2777674964 cites W2104607769 @default.
• W2777674964 cites W2105495610 @default.
• W2777674964 cites W2107972068 @default.
• W2777674964 cites W2108234281 @default.
• W2777674964 cites W2111326065 @default.
• W2777674964 cites W2126547130 @default.
• W2777674964 cites W2127990562 @default.
• W2777674964 cites W2131797874 @default.
• W2777674964 cites W2137518296 @default.
• W2777674964 cites W2139046059 @default.
• W2777674964 cites W2141458291 @default.
• W2777674964 cites W2142769937 @default.
• W2777674964 cites W2143296044 @default.
• W2777674964 cites W2149441684 @default.
• W2777674964 cites W2157012805 @default.
• W2777674964 cites W2159060826 @default.
• W2777674964 cites W2162525969 @default.
• W2777674964 cites W2164308593 @default.
• W2777674964 cites W2165392081 @default.
• W2777674964 cites W2170030318 @default.
• W2777674964 cites W2180425334 @default.
• W2777674964 cites W2192272998 @default.
• W2777674964 cites W2196610251 @default.
• W2777674964 cites W2255518001 @default.
• W2777674964 cites W2377560352 @default.
• W2777674964 cites W2409987903 @default.
• W2777674964 cites W2419582720 @default.
• W2777674964 cites W2462339434 @default.
• W2777674964 cites W2465616243 @default.
• W2777674964 cites W2508664218 @default.
• W2777674964 cites W2514723195 @default.
• W2777674964 cites W2555468434 @default.
• W2777674964 cites W2562844176 @default.
• W2777674964 cites W4231346141 @default.
• W2777674964 doi "https://doi.org/10.1124/jpet.117.244129" @default.
• W2777674964 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6040086" @default.
• W2777674964 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29263244" @default.
• W2777674964 hasPublicationYear "2017" @default.
• W2777674964 type Work @default.
• W2777674964 sameAs 2777674964 @default.
• W2777674964 citedByCount "70" @default.
• W2777674964 countsByYear W27776749642018 @default.
• W2777674964 countsByYear W27776749642019 @default.
• W2777674964 countsByYear W27776749642020 @default.
• W2777674964 countsByYear W27776749642021 @default.
• W2777674964 countsByYear W27776749642022 @default.
• W2777674964 countsByYear W27776749642023 @default.
• W2777674964 crossrefType "journal-article" @default.
• W2777674964 hasAuthorship W2777674964A5001388573 @default.
• W2777674964 hasAuthorship W2777674964A5003811693 @default.
• W2777674964 hasAuthorship W2777674964A5011186689 @default.
• W2777674964 hasAuthorship W2777674964A5034705456 @default.
• W2777674964 hasAuthorship W2777674964A5056562930 @default.
• W2777674964 hasAuthorship W2777674964A5057713208 @default.
• W2777674964 hasAuthorship W2777674964A5064561704 @default.
• W2777674964 hasAuthorship W2777674964A5065339919 @default.
• W2777674964 hasAuthorship W2777674964A5074720413 @default.
• W2777674964 hasAuthorship W2777674964A5075361012 @default.
• W2777674964 hasAuthorship W2777674964A5076653808 @default.
• W2777674964 hasBestOaLocation W27776749641 @default.
• W2777674964 hasConcept C101544691 @default.

• next